Trade

Chandra Bhagat Pharma share price

Extreme risk
  • 96%Low risk
  • 96%Moderate risk
  • 96%Balanced risk
  • 96%High risk
  • 96%Extreme risk
  • ₹40.10(-4.98%)
    February 18, 2026 14:40:09 PM IST
    • NSE
    • BSE
  • Vol : 1.00 K (NSE + BSE)
    Last 20 day avg : 5.65 K

Chandra Bhagat Pharma is trading -4.98% lower at Rs 40.10 as compared to its last closing price. Chandra Bhagat Pharma has been trading in the price range of 40.10 & 40.10. Chandra Bhagat Pharma has given 2.30% in this year & 0.00% in the last 5 days. Chandra Bhagat Pharma has TTM P/E ratio 51.90 as compared to the sector P/E of 29.67.The company posted a net profit of 0.45 Crores in its last quarter.Listed peers of Chandra Bhagat Pharma include Sun Pharmaceutical Industries (0.44%), Divi's Laboratories (1.37%), Torrent Pharmaceuticals (-1.20%).The Mutual Fund holding in Chandra Bhagat Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Chandra Bhagat Pharma was at 0.61% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 18, 2026, 10:07 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.17
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.70
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.06
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    50.93
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    20.42
    Indicates overvaluation
Price range
Day Range
Lowest
40.10
Highest
40.10
52 week range
Lowest
33.00
Highest
68.99
Chandra Bhagat Pharma Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,724.900.444,13,586.6435.485.650.970.50
Divi's Laboratories
Neutral
6,270.001.371,66,233.7974.4110.910.490.01
Torrent Pharmaceuticals
Bullish
4,207.50-1.201,42,269.9274.82190.8217.62
Cipla
Neutral
1,348.000.351,08,868.5820.813.510.960.81
Dr Reddy's Laboratories
Bullish
1,283.00-0.161,07,061.4018.683.150.632.34
Chandra Bhagat Pharma Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-13Half Yearly Results
2025-05-29Audited Results
2024-11-13Half Yearly Results
2024-05-30Audited Results
2023-11-09Half Yearly Results
About the company Chandra Bhagat Pharma
  • IndustryBiotechnology & Drugs
  • ISININE07QQ01016
  • BSE Code542934
  • NSE Code
Chandra Bhagat Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care centers for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.
  • Management Info
  • Hemant BhagatExecutive Chairman of the Board, Managing Director
  • Prachi BhagatChief Financial Officer, Executive Director
  • Rajni DawaniCompliance Officer, Company Secretary
  • Pranav BhagatWhole Time Director
Chandra Bhagat Pharma Share Price FAQs

Chandra Bhagat Pharma is trading at 40.10 as on Wed Feb 18 2026 09:10:09. This is -4.98% lower as compared to its previous closing price of 42.20.

The market capitalization of Chandra Bhagat Pharma is 30.26 Cr as on Wed Feb 18 2026 09:10:09.

The 52 wk high for Chandra Bhagat Pharma is 68.99 whereas the 52 wk low is 33.00

Chandra Bhagat Pharma can be analyzed on the following key metrics -

  • TTM P/E: 51.90
  • Sector P/E: 29.67
  • Dividend Yield: 0.00%
  • D/E ratio: 0.69

Chandra Bhagat Pharma reported a net profit of 0.86 Cr in 2025.

Quick Links
EQUITY QUICK LINKS
Chandra Bhagat Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Chandra Bhagat Pharma share price